The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID-19 who have mild symptoms and face a high risk of hospitalization. For ...
A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...
Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular ...
The impacts of highly pathogenic enveloped viruses, such as SARS-CoV-2, have turned scientific inquiry toward the fusion mechanisms responsible for viral pathogenesis and to seek cost-effective and ...
Neutralizing antibodies in the sera were measured at day 28 post-inoculation using the following authentic SARS-CoV-2 strains: wild-type D614G (left), Delta (middle), and BA.5 (right). Symbols ...
(C) SARS-CoV-2 spike protein staining in the nasal cavity sections and lungs determined via immunohistochemistry using a SARS-CoV-2 spike RBD-specific antibody. The proportion of positive cells in the ...
Therefore, elucidating the intimate mechanisms of the antiviral immune response is ... about whether prophylactic or therapeutic IFN administration might enhance SARS-CoV-2 entry and replication ...
On Wednesday, January 22, 2025, Dr. Danielle Beckman, Project Scientist at the California National Primate Research Center, USA, will give a seminar on “Sars-CoV-2 neuroinvasive potential and ...
SARS-CoV-2 continues to circulate and has become a common pathogen, and the fact that SARS-CoV-2 is still mutating and evolving new adaptation mechanisms makes combating this disease an ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback